发明名称 CANCER TREATMENT METHOD
摘要 Invented is a method of treating cancer or a pre-cancerous syndrome in a mammal, including a human, in need thereof which comprises the administration of an effective amount of a non-peptide thrombopoietin (TPO) receptor agonist to such mammal, suitably a human.
申请公布号 US2016235712(A1) 申请公布日期 2016.08.18
申请号 US201615062750 申请日期 2016.03.07
申请人 NOVARTIS AG 发明人 Erickson-Miller Connie L
分类号 A61K31/4152;A61K31/4155;A61K31/496;A61K9/00 主分类号 A61K31/4152
代理机构 代理人
主权项 1. A method of treating a disease state selected from: myelodysplastic syndrome and aplastic anemia, in a mammal in need thereof which comprises the in vivo administration of a therapeutically effective amount of a compound selected from: 3′-{N′-[1-(3,4-Dimethylphenyl)-3-methyl-5-oxo-1,5-dihydropyrazol-4-ylidene]hydrazino}-2′-hydroxybiphenyl-3-carboxylic acid; 3-{N′-[1-(3,4-dimethylphenyl)-3-methyl-5-oxo-1,5-dihydropyrazol-4-ylidene]hydrazino}-2-hydroxy-3′-tetrazol-5-ylbiphenyl; and 1-(3-chloro-5-{[4-(4-chlorothiophen-2-yl)-5-(4-cyclohexylpiperazin-1-yl)thiazol-2-yl]carbamoyl}pyridine-2-yl)piperidine-4-carboxylic acid;or a pharmaceutically acceptable salt thereof.
地址 Basel CH